Dubai, Ireland, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Fact.MR – A Market Research and Competitive Intelligence Provider: The global benzodiazepine drugs market is expected to witness a CAGR of 2.7% during the forecast period (2020-2026).
Surge in capital requirements for the development of quality branded drugs are pushing the adoption of generic drugs in the benzodiazepine drugs market. Moreover, Benzodiazepine drugs are used effectively for numerous disorders such as insomnia, anxiety, and seizures, which continue to push sales through multiple applications.
Rapid urbanization and modern work culture have an impact on the mental health. There is a surge in various issues such as insomnia, anxiety, and depression. Moreover, the geriatric population is also dealing with sleep and panic disorders. Rise in awareness among masses about the significance of mental health has boosted the demand for medication. In addition to this, significant demand for therapies such as cognitive behavioral therapy (CBT) and anti-depressants is witnessed in the recent years. Moreover, the above-mentioned factors are driving growth prospects in the benzodiazepine drugs market.
For more insights into the Market, Request Brochure of this Report
https://www.factmr.com/connectus/sample?flag=B&rep_id=4432
Besides this, various factors such as increasing benzodiazepine drug abuse and several reported cases of overdose, apart from increase in popularity of generic drugs, is resulting in slow growth of the market.
In addition to this, sizeable demand for various therapies such as cognitive behavior therapy (CBT) and anti-depressants is witnessed in last few years. These factors are expected to offer substantial growth prospects in the benzodiazepine drugs market.
Key Takeaways:
- North America dominated the market owing to rise in prevalence of anxiety and faster approvals of drug process by major players in the region.
- By application, benzodiazepine drugs for the treatment of anxiety alone are expected to account for over 53% share in the market by 2026. In the meanwhile, drug consumption for the treatment of seizures is likely to record a CAGR of around 2.4% during the forecast period.
- Moreover, sales of benzodiazepine drugs through online pharmacies are projected to witness a CAGR of around 3.5% and 3.4% in Asia Pacific and Latin America respectively.
Growth Drivers:
- Rapid urbanization and modern work culture is acting as a growth driver for the market. These factors lead to increase in issues such as depression and anxiety.
- Moreover, rise in awareness among the masses about the importance of mental health issues has boosted the demand for medications including benzodiazepine drugs.
- Rise in geriatric population and surge in sleep and panic disorders among them is expected to boost the growth of benzodiazepine drugs market.
- Key player’s emphasis on research and development to improve the effectiveness of benzodiazepine drugs is expected to contribute to the growth.
Restraints:
- Long-term consumption of benzodiazepine drugs is expected to cause various side effects such as dizziness, breathing problems, tremors, and brain damage. Side effects caused by drugs can act as a restraint to the growth of the market.
- Impact of stringent regulations against drug abuse is that sales of benzodiazepine drugs receive closure through retail and hospital pharmacies, as these drugs require a proper prescription.
For Comprehensive Insights Ask An Analyst Here
https://www.factmr.com/connectus/sample?flag=AE&rep_id=4432
Competitive Landscape:
The key market players in benzodiazepine drugs market are investing in R&D activities to enhance the effectiveness of benzodiazepine drugs used in various applications such as sedation, inducing sleep, and anxiety reduction with minimal side effects. Moreover, key players are also investing in smart-ups and using various strategies such as joint ventures, partnerships, acquisitions, and mergers in order to establish their foothold in the benzodiazepine drugs market.
Players in the benzodiazepine drugs market are putting emphasis on their distribution channels, which include pharmacies, retail pharmacies, hospitals, and online.
Key Companies Profiled by Fact.MR
Pfizer Inc., F.Hoffmann-La Roche Ltd., Bausch Health Companies, Inc., Mylan, N.V., Teva Pharmaceutical Industries Ltd., H.Lundbeck A/S, Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Apotex Inc., and Aurobindo Pharma.
More Valuable Insights on Benzodiazepine Drugs Market
Segmentation of Benzodiazepine drugs
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Others
By Time of Action:
- Ultra-short Acting
- Short Acting
- Long Acting
By Application:
- Anxiety
- Seizures
- Insomnia
- Alcohol Withdrawal
- Others
By Product:
- Alprazolam
- Clonazepam
- Diazepam
- Lorazepam
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Get Customization on this Report for Specific Research Solutions
https://www.factmr.com/connectus/sample?flag=RC&rep_id=4432
Explore Fact.MR’s Coverage on the Healthcare Domain
Preimplantation Genetic Testing Market - The preimplantation genetic testing market is projected to grow at nearly 9% CAGR and is likely to register an impressive valuation through 2031. Increasing prevalence of genetic disorders is broadening growth prospects.
Hospital Supplies Market - The increased use of preventative measures to manage and control hospital-acquired infections is expected to benefit the hospital supplies market (HAIs). Patients become infected with HAIs, also known as nosocomial infections, while undergoing medical or surgical treatment. The increasing number of surgical procedures suggests that the hospital supplies market has a lot of room to expand.
Automated External Defibrillators Market - The global automated external defibrillator market is expected to be worth US$ 17 Billion in 2022, with a CAGR of 11% during the forecast period. Sales of automated external defibrillators is expected to reach a valuation of US$ 48.26 Billion by 2032.
Medical Education Market - According to a study conducted by FAIMER International Medical Education Directory (IMED), the number of medical schools increased by more than 1/3rd between 2009 and 2013. Moreover, increase in new and non-traditional medical schools and student migration has prompted universities and institutions to provide quality education.
Blood Gas and Electrolyte Analyzer Market - This new Fact.MR survey projects worldwide blood gas and electrolyte analyzer shipments to increase at a CAGR of 5.6% from 2022 to 2030. Currently, the global blood gas and electrolyte analyzers market accounts for a valuation of US$ 4.2 billion and is projected to surge to US$ 6.5 billion by the end of 2032.
Cardiac Resynchronization Therapy Market - Newly-released Cardiac Resynchronization Therapy industry analysis report by Fact.MR shows that global sales of Cardiac Resynchronization Therapy in 2021 were held at US$ 5.7 Bn. With 7.9%, the projected market growth during 2022-2032 is expected to be slightly lower than the historical growth. CRT-Defibrillator is expected to be the higher revenue-generating product, accounting for an absolute dollar opportunity of nearly US$ 4 Bn during 2022 – 2032.
Portable Isolation Room Market - The global medical device market is undergoing significant changes owing to technological advancements to aid human health. The market is expected to expand at a CAGR of more than 5% with significant contribution from the isolation market over 2022-2032. Rapid increase in biologically-contaminated patients with COVID -19 has propelled the isolation market.
Minimally Invasive Surgery Market - During the past year, the industry registered a Y-o-Y increase worth 5.2%. From 2022 to 2032, the market is poised to flourish at a CAGR of 5.2% to reach a value of US$ 10.5 Billion.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. 80% of Fortune 1000's trusts us in critical decision making. We provide both qualitative and quantitative research, spanning market forecast, market segmentation, competitor analysis, and consumer sentiment analysis.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
